BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Oncolin Therapeutics, Inc. 

1330 Post Oak Boulevard
Suite 1600
Houston  Texas  77056  U.S.A.
Phone: 713-621-5208 Fax: 713-621-5336


SEARCH JOBS










 Company News
Oncolin Therapeutics, Inc. Board Not Able To Meet The Obligations Of An Early Stage Biotech Company Such As Intertech Bio 3/6/2009 9:25:24 AM    More...
Oncolin Therapeutics, Inc. Announces Appointment of Chair of Scientific Advisory Committee 7/17/2008 11:09:12 AM    More...
Oncolin Therapeutics, Inc. Announces the Discovery of a New More Effective Anti-Cancer Treatment in Experimental Brain Tumor Models 6/30/2008 9:46:07 AM    More...
Oncolin Therapeutics, Inc. Appoints Member of National Cancer Institute Advisory Board to its Scientific Advisory Board 6/23/2008 11:10:54 AM    More...
Oncolin Therapeutics, Inc. Announces Its Cancer Technology Will Be Presented at the 20th EORTC-NCI-AACR Symposium 6/19/2008 10:17:54 AM    More...
Oncolin Therapeutics, Inc. Signs Agreement with Leading Cancer Center 6/10/2008 9:22:44 AM    More...
Oncolin Therapeutics, Inc. Announces Its New 'Super Cell Blocker', ONC-127, Has Shown Effectiveness in Treating Cancer 5/14/2008 8:57:59 AM    More...
Oncolin Therapeutics, Inc. Announces That Dr. Randall K. Johnson Has Agreed to Join Its Scientific Advisory Board 5/6/2008 9:22:23 AM    More...
Oncolin Therapeutics, Inc. Announces the Addition of Dr. Sandra Silberman to Its Scientific Advisory Board 4/17/2008 9:50:01 AM    More...
Oncolin Therapeutics, Inc. Announces Its Lead Technology Has Shown to Be Effective in Treating Cancer in Animal Models 4/15/2008 10:11:17 AM    More...
12